Organon Acquired by Sun Pharma | Healthcare M&A Deal

Sun Pharma has acquired Organon, a pharmacy business in New Jersey, for $11.75B. The Organon acquisition brings a healthcare-focused portfolio spanning medicines and consumer health products, supporting Sun Pharma’s pharmacy acquisition strategy. Sun Pharma acquisitions in the U.S. strengthen healthcare M&A capabilities and expand product reach across key therapeutic areas. The merger acquisition is a strategic acquisition valued at $11.75 billion, structured as a definitive agreement and categorized as announced, with integration aimed at cost and revenue synergies.